methylphenidate has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kapellen, TM | 1 |
Reimann, R | 1 |
Kiess, W | 1 |
Kostev, K | 1 |
Abbott, MB | 1 |
Levin, RH | 1 |
1 review available for methylphenidate and Diabetes Mellitus, Type 1
Article | Year |
---|---|
What's new: newly approved drugs for children.
Topics: Adolescent; Age Factors; Albuterol; Androstadienes; Anticonvulsants; Asthma; Atovaquone; Attention D | 2001 |
1 other study available for methylphenidate and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Prevalence of medically treated children with ADHD and type 1 diabetes in Germany - Analysis of two representative databases.
Topics: Adolescent; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; C | 2016 |